Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Early Transcriptional Response in Ocular Hypertension in Living Human Retina
Author Affiliations & Notes
  • Alecia K Gross
    Neurobiology, The University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Mckenna Somerville
    Neurobiology, The University of Alabama at Birmingham, Birmingham, Alabama, United States
    Ophthalmology and Visual Sciences, The University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Ryan Strickland
    Neurobiology, The University of Alabama at Birmingham, Birmingham, Alabama, United States
    Ophthalmology and Visual Sciences, The University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Mary Anne Garner
    Neurobiology, The University of Alabama at Birmingham, Birmingham, Alabama, United States
    Ophthalmology and Visual Sciences, The University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Christopher A Girkin
    Ophthalmology and Visual Sciences, The University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Footnotes
    Commercial Relationships   Alecia Gross None; Mckenna Somerville None; Ryan Strickland None; Mary Anne Garner None; Christopher Girkin None
  • Footnotes
    Support  NIH grant EY035053
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 6140. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alecia K Gross, Mckenna Somerville, Ryan Strickland, Mary Anne Garner, Christopher A Girkin; Early Transcriptional Response in Ocular Hypertension in Living Human Retina. Invest. Ophthalmol. Vis. Sci. 2024;65(7):6140.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Elevated intraocular pressure is a primary risk factor for glaucomatous optic neuropathy. The acute
immune response to elevation in IOP in animal models has been described, however, the exact molecular
pathways that trigger these response remains unknown in the human eye. This study evaluates the impact of
acute elevation in IOP in the living human eye on transcriptional genes responsible for immune recruitment
seen with early injury in the retina.

Methods : Research-consented brain-dead organ donors underwent screening for inclusion criteria. Blood
pressure was monitored via an arterial line and tonometry was performed using an applanation tonometer.
The experimental eye received one hour of manometric pressure elevation at 50 mmHg via pars plana
cannulation while the fellow eye served as a control. Electroretinography was performed in regular intervals.
Ocular tissues were subsequently procured, dissected, formalin-fixed and paraffin embedded. Retina was
sliced in 5 µm sections, deparaffinized and RNA fluorescent in-situ hybridization was performed according to
RNAscope (Advanced Cell Diagnostics) protocol for FFPE tissues.

Results : Acute, 1-hour, sub-ischemic, increase in IOP results in an increase in transcripts involved in innate
immune activation as well as recruitment of peripheral immune effector cells. To date, we analyzed one
donor, and found an increase in chemokine ligand 2 (CCL2), FasR, cluster of differentiation 44 (CD44),
transforming growth factor beta 1 (TGF-β1). Analysis is ongoing.

Conclusions : Brief, acute increases in IOP results in alteration in the transcription of genes involved in early
immune and senescent pathways in the living human retina. Further studies of this acute response within the
living human eye could further elucidate early injurious pathways at the onset of ocular hypertension.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×